Sign In
Buy AMPH
$18.12
-0.330 (-1.79%)
At Close: Jun 03, 2026
Is Amphastar Pharmaceuticals (AMPH) Outperforming Other Medical Stocks This Year?
11:20am, Monday, 22'nd May 2023
Here is how Amphastar Pharmaceuticals (AMPH) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.
Amphastar (AMPH) Is a Great Choice for 'Trend' Investors, Here's Why
10:39am, Monday, 22'nd May 2023
If you are looking for stocks that are well positioned to maintain their recent uptrend, Amphastar (AMPH) could be a great choice. It is one of the several stocks that passed through our "Recent Price
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2023 Earnings Call Transcript
02:13pm, Saturday, 13'th May 2023
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH ) Q1 2023 Results Conference Call May 9, 2023 5:00 PM ET Company Participants Dan Dischner - VP of HR & Corporate Communication William Peters - CFO, Execu
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates
07:07pm, Tuesday, 09'th May 2023
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.47 per share a year ago.
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2023
04:30pm, Wednesday, 03'rd May 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 3, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2023 ended March 31, 2023, afte
Are Medical Stocks Lagging Amphastar Pharmaceuticals (AMPH) This Year?
11:28am, Wednesday, 26'th Apr 2023
Here is how Amphastar Pharmaceuticals (AMPH) and Addus HomeCare (ADUS) have performed compared to their sector so far this year.
Eli Lilly to sell Baqsimi diabetes drug to Amphastar for around $1 billion
12:30pm, Monday, 24'th Apr 2023
Eli Lilly and Co (NYSE:LLY) revealed that it will sell Baqsimi, its nasal treatment for severe hypoglycemia in people with diabetes, to Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) for around $1 billio
Eli Lilly to sell hypoglycemia treatment for up to $1.1 billion in cash and milestone payments to Amphastar
06:54am, Monday, 24'th Apr 2023
Shares of Eli Lilly & Co. LLY gained 0.5% in premarket trading Monday, after the drugmaker announced an agreement to sell its hypoglycemia treatment for people with diabetes Baqsimi to Amphastar Pharm
Amphastar Pharmaceuticals Business Update and Hold Conference Call on April 24th, 2023
12:00am, Monday, 24'th Apr 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 24, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will provide a Business update and hold a Conference call today, Monday, A
3 Profitable Stocks Worth a Buy Using Net Income Ratio
08:22am, Friday, 21'st Apr 2023
Amphastar Pharmaceuticals (AMPH), Alpha Metallurgical Resources (AMR) and Riley Exploration Permian (REPX) have been selected as the top picks with a high net income ratio.
Amphastar Pharmaceuticals Drug Stock Nears All-Time High After 74% Earnings Growth
04:53pm, Thursday, 20'th Apr 2023
This drug stock gained 35% since its earnings report. The biotech got FDA approval for its opioid overdose nasal spray.
Strength Seen in Amphastar (AMPH): Can Its 6.4% Jump Turn into More Strength?
01:42pm, Friday, 14'th Apr 2023
Amphastar (AMPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r
Amphastar Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
04:10pm, Wednesday, 12'th Apr 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 12, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, Jacob Liawatidewi, EVP of Corporate Administration, Tony Marrs
The Cream Of The Crop: 5 Biotech Stocks That Outrank 91% Of All Stocks
12:33pm, Friday, 24'th Mar 2023
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
Amphastar Pharmaceuticals (AMPH)'s Technical Outlook is Bright After Key Golden Cross
11:29am, Monday, 13'th Mar 2023
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
